273 related articles for article (PubMed ID: 22539846)
21. Modeling human methamphetamine use patterns in mice: chronic and binge methamphetamine exposure, reward function and neurochemistry.
Kesby JP; Chang A; Markou A; Semenova S
Addict Biol; 2018 Jan; 23(1):206-218. PubMed ID: 28224681
[TBL] [Abstract][Full Text] [Related]
22. Effects of repeated injections of cocaine on catecholamine receptor binding sites, dopamine transporter binding sites and behavior in rhesus monkey.
Farfel GM; Kleven MS; Woolverton WL; Seiden LS; Perry BD
Brain Res; 1992 Apr; 578(1-2):235-43. PubMed ID: 1380862
[TBL] [Abstract][Full Text] [Related]
23. Intracellular methamphetamine prevents the dopamine-induced enhancement of neuronal firing.
Saha K; Sambo D; Richardson BD; Lin LM; Butler B; Villarroel L; Khoshbouei H
J Biol Chem; 2014 Aug; 289(32):22246-57. PubMed ID: 24962577
[TBL] [Abstract][Full Text] [Related]
24. Atypical dopamine transporter inhibitors attenuate compulsive-like methamphetamine self-administration in rats.
Tunstall BJ; Ho CP; Cao J; Vendruscolo JCM; Schmeichel BE; Slack RD; Tanda G; Gadiano AJ; Rais R; Slusher BS; Koob GF; Newman AH; Vendruscolo LF
Neuropharmacology; 2018 Mar; 131():96-103. PubMed ID: 29217282
[TBL] [Abstract][Full Text] [Related]
25. Dose-Dependent Effects of Binge-Like Methamphetamine Dosing on Dopamine and Neurotrophin Levels in Rat Brain.
Moreira da Silva Santos A; Kelly JP; Doyle KM
Neuropsychobiology; 2017; 75(2):63-71. PubMed ID: 29065400
[TBL] [Abstract][Full Text] [Related]
26. Effects of chronic methamphetamine on psychomotor and cognitive functions and dopamine signaling in the brain.
Thanos PK; Kim R; Delis F; Rocco MJ; Cho J; Volkow ND
Behav Brain Res; 2017 Mar; 320():282-290. PubMed ID: 27993694
[TBL] [Abstract][Full Text] [Related]
27. Relationship of Alexithymia Ratings to Dopamine D2-type Receptors in Anterior Cingulate and Insula of Healthy Control Subjects but Not Methamphetamine-Dependent Individuals.
Okita K; Ghahremani DG; Payer DE; Robertson CL; Mandelkern MA; London ED
Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26657175
[TBL] [Abstract][Full Text] [Related]
28. A tryptamine-derived catecholaminergic enhancer, (-)-1-(benzofuran-2-yl)-2-propylaminopentane [(-)-BPAP], attenuates reinstatement of methamphetamine-seeking behavior in rats.
Hiranita T; Yamamoto T; Nawata Y
Neuroscience; 2010 Jan; 165(2):300-12. PubMed ID: 19883738
[TBL] [Abstract][Full Text] [Related]
29. Neural Correlates of Exposure to Cocaine Cues in Rhesus Monkeys: Modulation by the Dopamine Transporter.
Porrino LJ; Miller MD; Smith HR; Nader SH; Nader MA
Biol Psychiatry; 2016 Nov; 80(9):702-710. PubMed ID: 27059874
[TBL] [Abstract][Full Text] [Related]
30. Methamphetamine-induced striatal dopamine release, behavior changes and neurotoxicity in BALB/c mice.
Kita T; Matsunari Y; Saraya T; Shimada K; O'Hara K; Kubo K; Wagner GC; Nakashima T
Int J Dev Neurosci; 2000 Oct; 18(6):521-30. PubMed ID: 10884597
[TBL] [Abstract][Full Text] [Related]
31. Decrease of D2 receptor binding but increase in D2-stimulated G-protein activation, dopamine transporter binding and behavioural sensitization in brains of mice treated with a chronic escalating dose 'binge' cocaine administration paradigm.
Bailey A; Metaxas A; Yoo JH; McGee T; Kitchen I
Eur J Neurosci; 2008 Aug; 28(4):759-70. PubMed ID: 18671743
[TBL] [Abstract][Full Text] [Related]
32. Methamphetamine influences on recognition memory: comparison of escalating and single-day dosing regimens.
Belcher AM; Feinstein EM; O'Dell SJ; Marshall JF
Neuropsychopharmacology; 2008 May; 33(6):1453-63. PubMed ID: 17637607
[TBL] [Abstract][Full Text] [Related]
33. Age as a susceptibility factor in the striatal dopaminergic neurotoxicity observed in the mouse following substituted amphetamine exposure.
Miller DB; O'Callaghan JP; Ali SF
Ann N Y Acad Sci; 2000 Sep; 914():194-207. PubMed ID: 11085321
[TBL] [Abstract][Full Text] [Related]
34. Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure.
McFadden LM; Hadlock GC; Allen SC; Vieira-Brock PL; Stout KA; Ellis JD; Hoonakker AJ; Andrenyak DM; Nielsen SM; Wilkins DG; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2012 Feb; 340(2):295-303. PubMed ID: 22034657
[TBL] [Abstract][Full Text] [Related]
35. Effect of a binge-like dosing regimen of methamphetamine on dopamine levels and tyrosine hydroxylase expressing neurons in the rat brain.
Moreira da Silva Santos A; Kelly JP; Dockery P; Doyle KM
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():303-309. PubMed ID: 30296469
[TBL] [Abstract][Full Text] [Related]
36. Striatal and extrastriatal dopamine release in the common marmoset brain measured by positron emission tomography and [(18)F]fallypride.
Ota M; Ogawa S; Kato K; Masuda C; Kunugi H
Neurosci Res; 2015 Dec; 101():1-5. PubMed ID: 26232153
[TBL] [Abstract][Full Text] [Related]
37. Prior methamphetamine self-administration attenuates the dopaminergic deficits caused by a subsequent methamphetamine exposure.
McFadden LM; Vieira-Brock PL; Hanson GR; Fleckenstein AE
Neuropharmacology; 2015 Jun; 93():146-54. PubMed ID: 25645392
[TBL] [Abstract][Full Text] [Related]
38. Impairments in timing, temporal memory, and reversal learning linked to neurotoxic regimens of methamphetamine intoxication.
Cheng RK; Etchegaray M; Meck WH
Brain Res; 2007 Dec; 1186():255-66. PubMed ID: 17996849
[TBL] [Abstract][Full Text] [Related]
39. Dopaminergic involvement in the discriminative-stimulus effects of methamphetamine in rats.
Munzar P; Goldberg SR
Psychopharmacology (Berl); 2000 Feb; 148(2):209-16. PubMed ID: 10663437
[TBL] [Abstract][Full Text] [Related]
40. Effect of methamphetamine self-administration on tyrosine hydroxylase and dopamine transporter levels in mesolimbic and nigrostriatal dopamine pathways of the rat.
Shepard JD; Chuang DT; Shaham Y; Morales M
Psychopharmacology (Berl); 2006 May; 185(4):505-13. PubMed ID: 16555063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
